2020 Cannabis Innovations Report
2020 Cannabis Innovations Report
Despite a difficult 2019 followed by a pandemic in 2020, the Brightfield Group reports 912 new products launched in the first 3 quarters of 2020. We’ll reveal the most successful new product launches this year.
We’ll look at the high-level cannabis trends then dive into the data and explore the products that won on shelves this year.
Although strapped for funding, brands had to be strategic with the products they brought to market- they couldn’t afford a flop. The innovations this year is reflecting a maturing market, interest in cannabinoids beyond THC & CBD, and of course ever-changing consumer behavior.
Show Notes:
2020 In Review: Cannabis Innovation Report
https://content.brightfieldgroup.com/cannabis-innovations-2020-year-in-review
Host:
Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast.
https://www.linkedin.com/in/joshkincaid/
Episode 610 of The Talking Hedge:
Your Cannabis Business Podcast.
Covering cannabis products, reviews, business news, interviews, investments, events, and more.
https://www.theTalkingHedgepodcast.com
Music Info:
Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018Artist: LuxrayBeats
Keywords:
Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data
Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.
There’s no doubt that "cleaner" and "healthier" ( relatively ) methods of administration are gaining market share. The increasing age of the very large "baby-boomer" population, those who first popularized both medical and recreational cannabis, has a lot to do with that trend. ( guilty as charged ) But, the edibles have significant issues that can’t be sidestepped: the long delay before onset, and the difficulty of self-titration. Many consumer products that affect the mind & body have quick onset. Alcohol and tobacco, coffee and tea, all have rapid onset. I see "recreation" as better suited to quick onset methods, and "medication" as better suited to slower acting products and I suspect the market will move in that direction. But … what do I know? I was reminded recently of a quotation from a politician who was asked his opinion of a bitterly fought and close election that he had just lost. He said: "The people have spoken …. the bastards."